| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/16/2001 | US20010014357 Citrus peel extract as inhibitor of ACYL coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 08/16/2001 | US20010014319 Defective recombinant virus containing at least one inserted gene encoding all or part of lecithin-cholesterol acyltransferase (LCAT) or a variant thereof; treating or preventing dyslipoproteinaemia-related diseases |
| 08/16/2001 | EP1144997A3 Methods and compounds for modulating nuclear receptor activity |
| 08/16/2001 | EP1144373A3 Serine protease inhibitors |
| 08/16/2001 | EP1143946A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | EP1123926A1 Piperazine derivatives for treatment of CNS disorders |
| 08/16/2001 | EP1123925A1 Process for preparation of substituted pyridines |
| 08/16/2001 | EP1123924A1 Substituted pyridines as HMG-COA reductase inhibitors |
| 08/16/2001 | EP1123922A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 08/16/2001 | EP1123717A2 Estrogen agonist/antagonist and statin containing compositions for treating osteoporosis and lowering cholesterol |
| 08/16/2001 | EP1123393A1 Follistatin-related protein zfsta2 |
| 08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
| 08/16/2001 | EP1123368A1 Method of extracting lipids from marine and aquatic animal tissues |
| 08/16/2001 | EP1123306A1 Inhibitors of platelet activation and recruitment |
| 08/16/2001 | EP1123297A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123296A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 08/16/2001 | EP1123295A1 Bicyclic nitrogen heterocycles |
| 08/16/2001 | EP1123292A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123283A1 Thiazole-derivatives |
| 08/16/2001 | EP1123280A1 Serine protease inhibitor |
| 08/16/2001 | EP1123279A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123276A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 08/16/2001 | EP1123274A1 Substituted phenyl derivatives, their preparation and use |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP1123269A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123268A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123267A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123129A1 Systems and compounds for drug delivery to interstitial regions of the myocardium |
| 08/16/2001 | EP1123115A1 Treatment of trauma (ie graft rejection) with liposomes containing dna encoding for ctla4ig or for anti cd40l |
| 08/16/2001 | EP1123109A1 Contulakin-g, analogs thereof and uses therefor |
| 08/16/2001 | EP1123096A1 Bioflavonoids as plasma high density lipoprotein level increasing agent |
| 08/16/2001 | EP1123094A1 Therapeutic compositions (ii) |
| 08/16/2001 | EP1035851B1 Endothelin receptor antagonists for combating hyperlipidaemia |
| 08/16/2001 | EP0944388A4 Inhibitors of farnesyl-protein transferase |
| 08/16/2001 | EP0805817B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 08/16/2001 | EP0688330B1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
| 08/16/2001 | EP0628042B1 Serotoninergic ergoline derivatives |
| 08/16/2001 | EP0558677B1 Biologically active amines |
| 08/16/2001 | DE10006139A1 Indol-3-yl-Derivate Indol-3-yl derivatives |
| 08/16/2001 | DE10004858A1 Verwendung von Proteinkinase-Inhibitor-alpha The use of protein kinase inhibitor alpha- |
| 08/16/2001 | DE10004857A1 MLP-Gen, Nukleinsäuren, Polypeptide und deren Verwendung MLP-gene nucleic acids, polypeptides and their use |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2416343A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | CA2400497A1 Methods and compositions for generating angiostatin |
| 08/16/2001 | CA2400488A1 Methods for the prevention and treatment of infections using anti-c3b(i) antibodies |
| 08/16/2001 | CA2400187A1 Protein c derivatives |
| 08/16/2001 | CA2399799A1 2-phenylcarbamoyl-benzimidazoles |
| 08/16/2001 | CA2399795A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 08/16/2001 | CA2399436A1 Method of treating or inhibiting cellular injury or cell death |
| 08/16/2001 | CA2399421A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
| 08/16/2001 | CA2399396A1 Tnf- .alpha. inhibitors |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399349A1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2398984A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398282A1 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | CA2398007A1 Use of pyrimidine endothelin antagonists in companion animals |
| 08/15/2001 | CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308631A Heterocyclic derivatives which inhibit factor xa |
| 08/15/2001 | CN1308630A Benzocarbazole and indenoindole derived estrogenic agents |
| 08/15/2001 | CN1308619A (2-acylaminothiazole-4-yl) acetic acid derivatives |
| 08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
| 08/15/2001 | CN1308609A Method of locking 1 & alpha, -OH of vitamin d compounds in axial orientation |
| 08/15/2001 | CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 08/15/2001 | CN1308526A Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 08/15/2001 | CN1308525A Transdermal plaster containing at least one active ingredient which infuences blood serum lipid levels |
| 08/15/2001 | CN1308523A Pellets having a core coated with a lipid lowering agent and a polymer |
| 08/15/2001 | CN1308492A Hypericin and i(hypericum) extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics |
| 08/15/2001 | CN1308069A Substittued (dihydro)benzoxazole and (dihydro)benzoxazine compound and their preparation and medicine composite |
| 08/15/2001 | CN1307901A Treating synergist composite and its usage |
| 08/15/2001 | CN1307896A Preparation of pile-eliminating turtle shell capsule |
| 08/15/2001 | CN1307888A Medicine for treating hypertension and heart disease and its preparation |
| 08/15/2001 | CN1307887A Medicine composite and its preparation |
| 08/15/2001 | CN1307884A Angitis treating medicine |
| 08/15/2001 | CN1307876A Xinmaikang medicine |
| 08/15/2001 | CN1069540C preparation process of compound red sage tablet |
| 08/15/2001 | CN1069532C Medicine for preventing hypertension cere hemorrhage |
| 08/15/2001 | CN1069531C Chinese medicine compositions for treatment of angiocardiopathy and cerebrovascular disease |
| 08/15/2001 | CN1069525C Turtle oil, soft-shelled turtle oil compositions and the preparation thereof |
| 08/15/2001 | CN1069520C Erigeron berviscopus element soft capsule and production method thereof |
| 08/15/2001 | CA2337381A1 Compositions and methods for treating osteoporosis |
| 08/14/2001 | US6274736 Chromatographic enantiomer separation of lactones |
| 08/14/2001 | US6274619 Amidino substituted tetrahydrobenzo thiophene or furan derivatives and their use as urokinase inhibitors |
| 08/14/2001 | US6274616 ((3-(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2 -methyl-1h-indol-4-yl)oxy)acetic acid n,n-diethylglycolamidoester used for inhibiting human non-pancreatic secretory phopholipase a2 mediated release of |
| 08/14/2001 | US6274594 Isoquinoline derivatives and their therapeutical use |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274582 Reduction of visceral fat |
| 08/14/2001 | US6274581 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 08/14/2001 | US6273908 Stents |
| 08/14/2001 | CA2248955C The use of fumaric acid derivatives |
| 08/14/2001 | CA2198570C New derivatives of boronic acid, the process for producing said derivatives and the pharmaceutical compound that contain them |
| 08/14/2001 | CA2148380C 5-arylindole derivatives |
| 08/14/2001 | CA2035179C Pharmaceutical compositions containing insoluble salts of bisphosphonic acids |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057240A2 Interaction of nmda receptor with protein tyrosine phosphatase |